Invesco S&P 500 Equal Weight Health Care ETF (RYH) Stock Analysis
DELISTED 2025
What happened to Invesco S&P 500 Equal Weight Health Care ETF (RYH) stock?
Invesco S&P 500 Equal Weight Health Care ETF (RYH) no longer trades on public markets. It was delisted in July 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Invesco S&P 500 Equal Weight Health Care ETF (RYH) trades at $287.06. Invesco S&P 500 Equal Weight Health Care ETF (RYH) aims to replicate the performance of the S&P 500 Health Care Index. Market cap: $953M, Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for RYH: RYH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RYH against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
RYH: the 2 scored disciplines are evenly split. Dominant signal: Jim Simons bullish.
How is this calculated? →Invesco S&P 500 Equal Weight Health Care ETF (RYH) Financial Services Profile
Invesco S&P 500 Equal Weight Health Care ETF (RYH) offers investors equal-weighted exposure to the health care sector within the S&P 500, differentiating itself through its weighting methodology, which mitigates concentration risk compared to market-cap-weighted healthcare ETFs, providing a diversified approach to investing in healthcare equities.
What Is the Investment Thesis for RYH?
RYH presents an investment opportunity for those seeking diversified exposure to the health care sector. Its equal-weighting strategy mitigates concentration risk, offering a more balanced representation of the sector compared to market-cap-weighted alternatives. The fund's expense ratio and tracking error relative to the S&P 500 Health Care Index are key factors to monitor. Growth catalysts include increased investor interest in sector-specific ETFs and the continued expansion of the health care industry. Potential risks include regulatory changes impacting the health care sector and fluctuations in market sentiment towards health care stocks. The fund's beta of 0.84 suggests lower volatility compared to the broader market. With a market cap of $953M, RYH offers sufficient liquidity for institutional investors.
Based on FMP financials and quantitative analysis
RYH Key Highlights
RYH's investment strategy focuses on mirroring the S&P 500 Health Care Index, minimizing active management and associated costs.
- The fund's equal-weighting approach provides a more balanced exposure to the health care sector, encompassing pharmaceuticals, biotechnology, healthcare equipment, and healthcare services.
- RYH's beta of 0.84 indicates lower volatility compared to the S&P 500 Index.
- As of March 18, 2026, RYH has a market capitalization of $953M, reflecting its established presence in the ETF market.
- RYH does not offer a dividend yield, which may be a consideration for income-focused investors.
Who Are RYH's Competitors?
RYH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IBDL iShares iBonds Dec 2020 Term Corporate ETF | $25.20 | +0.04% | $953M | 44 |
| JKG iShares Morningstar Mid-Cap ETF | $251.08 | -0.21% | $992M | — |
| JKH iShares Morningstar Mid-Cap Growth ETF | $374.17 | +1.18% | $898M | — |
| QWST Harbor ETF Trust - Harbor Small Cap Explorer ETF | $32.02 | -0.02% | $819M | — |
| RGI Invesco S&P 500 Equal Weight Industrials ETF | $189.57 | +0.28% | $348M | — |
| MUC BlackRock MuniHoldings California Quality Fund, Inc. | $10.60 | -0.75% | $998M | 67 |
| FSCO FS Credit Opportunities Corp. | $5.14 | -0.58% | $1.04B | 93 |
| GSBD Goldman Sachs BDC, Inc. | $9.88 | +0.82% | $1.11B | 91 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RYH's Key Strengths?
Equal-weighting strategy mitigates concentration risk.
- Diversified exposure to the health care sector.
- Passive management results in lower expense ratios.
- Established brand recognition of Invesco.
What Are RYH's Weaknesses?
No dividend yield may deter income-focused investors.
- Performance is tied to the S&P 500 Health Care Index, limiting potential for outperformance.
- Vulnerable to sector-specific risks and regulatory changes.
- May not appeal to investors seeking active management.
What Could Drive RYH Stock Higher?
Increased investor interest in sector-specific ETFs.
- Continued expansion of the health care industry.
- Potential for new strategic partnerships and distribution agreements.
- Launch of innovative ETF products focused on emerging trends in healthcare.
What Are the Key Risks for RYH?
Regulatory changes impacting the health care sector.
- Fluctuations in market sentiment towards health care stocks.
- Economic downturns affecting the health care industry.
- Competition from other health care ETFs.
- Dependence on the performance of the S&P 500 Health Care Index.
What Are the Growth Opportunities for RYH?
- Increased Adoption of Sector-Specific ETFs: The growing trend of investors allocating capital to sector-specific ETFs presents a significant growth opportunity for RYH. As investors seek targeted exposure to specific industries, RYH's equal-weighted approach to the health care sector becomes increasingly attractive. The market for sector ETFs is projected to reach $1 trillion by 2028, offering substantial room for growth. RYH can capitalize on this trend by highlighting its diversification benefits and consistent tracking of the S&P 500 Health Care Index.
- Expansion of the Health Care Industry: The health care industry is experiencing continuous growth driven by factors such as an aging population, advancements in medical technology, and increasing healthcare spending. This growth translates into increased opportunities for companies within the S&P 500 Health Care Index, which in turn benefits RYH. The global healthcare market is expected to reach $13 trillion by 2030, providing a strong tailwind for RYH's performance. RYH's exposure to various sub-sectors within healthcare allows it to capture growth across the industry.
- Rising Demand for Diversified Investment Strategies: Investors are increasingly seeking diversified investment strategies to mitigate risk and enhance returns. RYH's equal-weighting methodology offers a more balanced representation of the health care sector compared to market capitalization-weighted ETFs, appealing to investors seeking diversification. The demand for diversified investment products is expected to grow as investors become more risk-averse. RYH can leverage this trend by emphasizing its diversification benefits and its ability to provide exposure to a broad range of health care companies.
- Strategic Partnerships and Distribution Agreements: Forming strategic partnerships with financial advisors and distribution platforms can significantly expand RYH's reach and increase its assets under management (AUM). By collaborating with key players in the financial industry, RYH can gain access to a wider pool of potential investors. The ETF distribution landscape is evolving, with new platforms and channels emerging regularly. RYH can capitalize on these opportunities by forging strategic alliances and expanding its distribution network.
- Innovation in ETF Product Development: Continuously innovating and developing new ETF products that cater to specific investor needs can drive growth for Invesco. This includes exploring thematic ETFs focused on emerging trends within the health care sector, such as telemedicine, personalized medicine, and digital health. The ETF market is highly competitive, with providers constantly innovating to attract assets. By staying ahead of the curve and developing innovative ETF products, Invesco can maintain its competitive edge and attract new investors.
What Are RYH's Competitive Advantages?
- Established Brand Recognition: Invesco is a well-known and respected asset manager, providing RYH with a competitive advantage.
- Passive Management Strategy: The fund's passive management approach results in lower expense ratios compared to actively managed funds.
- Equal-Weighting Methodology: RYH's equal-weighting strategy differentiates it from market capitalization-weighted ETFs.
- Diversified Exposure: The fund provides exposure to a broad range of companies within the health care sector.
What Does RYH Do?
The Invesco S&P 500 Equal Weight Health Care ETF (RYH) is designed to track the performance of the S&P 500 Health Care Index. This index comprises all companies within the S&P 500 Index that are classified as members of the health care sector according to the Global Industry Classification Standard (GICS). RYH employs a passive management strategy, seeking to replicate the index's composition and weighting. Unlike market capitalization-weighted ETFs, RYH equally weights each constituent, preventing larger companies from dominating the fund's performance. This approach offers investors a more balanced exposure to the health care sector, encompassing pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. The fund invests at least 90% of its total assets in the securities of the underlying index. By equally weighting its holdings, RYH aims to reduce concentration risk and provide a more diversified representation of the health care sector's performance. The ETF's investment strategy focuses on mirroring the index, minimizing active management and associated costs. As of March 18, 2026, RYH continues to provide investors with a strategic tool for accessing the health care sector through an equal-weighted approach.
What Products and Services Does RYH Offer?
- Tracks the performance of the S&P 500 Health Care Index.
- Invests at least 90% of its assets in securities comprising the underlying index.
- Provides exposure to companies in the health care sector, including pharmaceuticals, biotechnology, and healthcare services.
- Employs an equal-weighting strategy, mitigating concentration risk.
- Offers a diversified approach to investing in health care equities.
- Seeks to replicate the index's composition and weighting.
How Does RYH Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Aims to provide investment results that correspond generally to the performance of its underlying index.
- Offers investors a convenient and cost-effective way to access the health care sector.
- Operates as a passively managed ETF, minimizing active trading and research costs.
What Industry Does RYH Operate In?
The asset management industry is characterized by increasing demand for specialized ETFs, particularly those focused on specific sectors like healthcare. The healthcare sector itself is experiencing growth driven by an aging population, technological advancements, and increasing healthcare spending. RYH competes with other healthcare ETFs, including market capitalization-weighted funds and actively managed funds. Its equal-weighting strategy differentiates it from competitors, appealing to investors seeking diversification within the healthcare sector. The ETF market is highly competitive, with providers continually innovating to attract assets and improve performance.
Who Are RYH's Key Customers?
- Institutional investors seeking diversified exposure to the health care sector.
- Financial advisors looking for sector-specific ETFs to incorporate into client portfolios.
- Retail investors interested in investing in the health care industry.
- Pension funds and endowments seeking to allocate capital to the health care sector.
RYH Financials
Bull Case vs Bear Case
Bull Case
- Equal-weighting strategy mitigates concentration risk.
- Diversified exposure to the health care sector.
- Passive management results in lower expense ratios.
- Established brand recognition of Invesco.
Bear Case
- No dividend yield may deter income-focused investors.
- Performance is tied to the S&P 500 Health Care Index, limiting potential for outperformance.
- Vulnerable to sector-specific risks and regulatory changes.
- May not appeal to investors seeking active management.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
RYH Latest News
No recent news available for RYH.
What Investors Ask About Invesco S&P 500 Equal Weight Health Care ETF (RYH) — Financial Services
What happened to Invesco S&P 500 Equal Weight Health Care ETF (RYH) stock?
Invesco S&P 500 Equal Weight Health Care ETF (RYH) no longer trades on public markets. It was delisted in July 2025. The figures below are historical and are not a current quote.
Can I still buy RYH shares?
No. RYH stopped trading on public markets in July 2025, so the shares are not available through a broker. Anything you see quoted for RYH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RYH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Invesco S&P 500 Equal Weight Health Care ETF. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Invesco S&P 500 Equal Weight Health Care ETF do?
Invesco S&P 500 Equal Weight Health Care ETF (RYH) is designed to track the performance of the S&P 500 Health Care Index. The fund invests at least 90% of its total assets in the securities that comprise the underlying index. Unlike market capitalization-weighted ETFs, RYH equally weights each constituent, preventing larger companies from dominating the fund's performance.
What are the main risks for RYH?
The main risks for RYH include regulatory changes impacting the health care sector, fluctuations in market sentiment towards health care stocks, and economic downturns affecting the health care industry. Competition from other health care ETFs and dependence on the performance of the S&P 500 Health Care Index are also key risks.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for RYH, limiting the availability of analyst insights.
- The information provided is based on available data and may be subject to change.